CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Sunrest Lifescience Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Sunrest Lifescience Ltd
Phone: +91 7929918245p:+91 7929918245 AHMEDABAD, 382415  India Ticker: SUNRESTSUNREST
Business Summary
Sunrest Lifescience Limited is an India-based pharmaceutical company. The Company is engaged in the marketing of over the counter (OTC) generic pharmaceutical products manufactured by third party manufacturers in the domestic market. It deals in capsules, tablets, syrup, ointment, gel, mouth wash, solution, suspension, dry powders and toothpaste. The Company’s product portfolio comprises a range of drugs like Anti-Bacterial, Anti Diarrheal, Antifungal, Anti Malerial, Anti Diabetic, Dental Cure, Anti Protozol, Anti Histamine, Anti-Hypertensive drugs, Cosmetic, Anti Parasitic, Multivitamin, Multimineral, Nutraceutical and Anti-inflammatory. The Company operates in different States of India, such as Maharashtra, Gujarat, Madhya Pradesh, Orissa and Rajasthan. The products of the Company are sold to stockists and in turn it is available at chemist shops, dispensaries, and hospitals, among others.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/20233/31/2023-----

Industries
SIC Code Description
5122 Drugs, drug proprietaries, and druggists' sundries
2834 Pharmaceutical preparations
8742 Management consulting services

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Non-Executive Independent Chairman of the Board JuhiSawajani 27 3/6/2023 3/1/2023
Chief Financial Officer Meha B.Parekh 3/1/2023 3/1/2023
Compliance Officer, Company Secretary Nishi B.Shah 3/1/2023 3/1/2023
6 additional Officers and Directors records available in full report.

General Information
Outstanding Shares: 4,291,200 (As of 6/30/2023)
Stock Exchange: NSE
Email Address: info@sunrestlifescience.com


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, April 27, 2024